Cargando…
Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats
Mesenchymal stem cells (MSCs) have innate ability to self-renew and immunosuppressive functions, and differentiate into various cell types. They have become a promising cell source for treating many diseases, particular for bone regeneration. Osteoporosis is a common metabolic bone disorder with ele...
Autores principales: | Huang, Shuo, Xu, Liangliang, Sun, Yuxin, Lin, Sien, Gu, Weidong, Liu, Yamei, Zhang, Jinfang, Chen, Lin, Li, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053541/ https://www.ncbi.nlm.nih.gov/pubmed/27711227 http://dx.doi.org/10.1371/journal.pone.0163131 |
Ejemplares similares
-
Correction: Systemic Administration of Allogeneic Mesenchymal Stem Cells Does Not Halt Osteoporotic Bone Loss in Ovariectomized Rats
por: Huang, Shuo, et al.
Publicado: (2017) -
Ginsenoside Rb1 does not halt osteoporotic bone loss in ovariectomized rats
por: Bei, JiaXin, et al.
Publicado: (2018) -
The fate of systemically administrated allogeneic mesenchymal stem cells in mouse femoral fracture healing
por: Huang, Shuo, et al.
Publicado: (2015) -
Scopolin Attenuates Osteoporotic Bone Loss in Ovariectomized Mice
por: Park, Eunkuk, et al.
Publicado: (2020) -
Osteoporotic Characteristics Persist in the Spine of Ovariectomized Sheep after Withdrawal of Corticosteroid Administration
por: Zarrinkalam, Mohammad-Reza, et al.
Publicado: (2012)